Procurement Summary
Country: Brazil
Summary: Acquisition of Medicines.
Deadline: 07 May 2026
Posting Date: 16 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 139640889
Document Ref. No.: 91058/2025
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Acquisition of MEDICINES. UASG code: 925998 Notice from: 04/16/2026 from 08:00 to 14:00 Proposal Delivery: from 04/16/2026 at 08:00 BRINZOLAMIDE, CONCENTRATION 10 MG/ML, PHARMACEUTICAL FORM SUSPENSION OPHTHALMIC Quantity: 359 ETOSUXIMIDE, DOSAGE 50 MG/ML, SYRUP PRESENTATION Quantity: 172 MEPOLIZUMAB, CONCENTRATION 100 MG/ML, INJECTABLE PHARMACEUTICAL FORM Quantity: 147 MEPOLIZUMAB, CONCENTRATION 100 MG/ML, INJECTABLE PHARMACEUTICAL FORM Quantity: 9 PILOCARPINE HYDROCHLORIDE, 2% CONCENTRATION, INDICATION OPHTHALMIC SOLUTION Quantity: 31 TIOTROPIE BROMIDE, COMPOSITION ASSOCIATED WITH OLODATEROL, CONCENTRATION 2.5 MCG/DOSE + 2.5 MCG/DOSE, PHARMACEUTICAL FORM SOLUTION FOR INHALATION, ADDITIONAL CHARACTERISTICS WITH INHALER Quantity: 25007 TIOTROPE BROMIDE, COMPOSITION ASSOCIATED WITH OLODATEROL, CONCENTRATION 2.5 MCG/DOSE + 2.5 MCG/DOSE, PHARMACEUTICAL FORM SOLUTION FOR INHALATION, ADDITIONAL CHARACTERISTICS WITH INHALER Quantity: 327 TIOTROPE BROMIDE, SALT COMPOSITION BROMIDE, CONCENTRATION 2.5 MCG/DOSE, PHARMACEUTICAL FORM SOLUTION FOR INHALATION, ADDITIONAL CHARACTERISTICS WITH INHALER Quantity: 17484 TIOTROPIE BROMIDE, COMPOSITION SALT BROMIDE, CONCENTRATION 2.5 MCG/DOSE, PHARMACEUTICAL FORM SOLUTION FOR INHALATION, CHARACTERISTICS ADDITIONAL WITH INHALER Quantity: 213 TRIPTORRELIN, SOFT SALT COMPOSITION, CONCENTRATION 3.75 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION Quantity: 16 UMECLIDINIUM BROMIDE, COMPOSITION ASSOCIATED WITH VILANTEROL TRIFENATATE, CONCENTRATION 62.5 MCG/DOSE + 25 MCG/DOSE, PHARMACEUTICAL FORM INHALER POWDER, ADDITIONAL WITH INHALER Quantity: 25062 UMECLIDINIUM BROMIDE, COMPOSITION ASSOCIATED WITH VILANTEROL TRIFENATATE, CONCENTRATION 62.5 MCG/DOSE + 25 MCG/DOSE, PHARMACEUTICAL FORM INHALED POWDER, ADDITIONAL WITH INHALER Quantity: 272
Documents
Tender Notice